Ward, KM, Aletras, AH, Balaban, RS. A new class of contrast agents for MRI based on proton chemical exchange dependent saturation transfer (CEST). J Magn Reson 2000, 143:79–87.
Zhou, J, Wilson, DA, Sun, PZ, Klaus, JA, Van Zijl, PC. Quantitative description of proton exchange processes between water and endogenous and exogenous agents for WEX, CEST, and APT experiments. Magn Reson Med 2004, 51:945–952.
Zhang, S, Winter, P, Wu, K, Sherry, AD. A novel europium(III)‐based MRI contrast agent. J Am Chem Soc 2001, 123:1517–1518.
Hancu, I, Dixon, WT, Woods, M, Vinogradov, E, Sherry, AD, Lenkinski, RE. CEST and PARACEST MR contrast agents. Acta Radiol 2010, 51:910–923.
Woods, M, Woessner, DE, Sherry, AD. Paramagnetic lanthanide complexes as PARACEST agents for medical imaging. Chem Soc Rev 2006, 35:500–511.
Cai, K, Kiefer, GE, Caruthers, SD, Wickline, SA, Lanza, GM, Winter, PM. Quantification of water exchange kinetics for targeted PARACEST perfluorocarbon nanoparticles. NMR Biomed 2011, 25: 279–285.
Fisher, JP, Dean, D, Mikos, AG. Photocrosslinking characteristics and mechanical properties of diethyl fumarate/poly(propylene fumarate) biomaterials. Biomaterials 2002, 23:4333–4343.
Vasalatiy, O, Gerard, RD, Zhao, P, Sun, X, Sherry, AD. Labeling of adenovirus particles with PARACEST agents. Bioconjug Chem 2008, 19:598–606.
Vinogradov, E, Zhang, S, Lubag, A, Balschi, JA, Sherry, AD, Lenkinski, RE. On‐resonance low B1 pulses for imaging of the effects of PARACEST agents. J Magn Reson 2005, 176:54–63.
Li, AX, Suchy, M, Li, C, Gati, JS, Meakin, S, Hudson, RH, Menon, RS, Bartha, R. In vivo detection of MRI‐PARACEST agents in mouse brain tumors at 9.4 T. Magn Reson Med 2011, 66:67–72.
Liu, G, Ali, MM, Yoo, B, Griswold, MA, Tkach, JA, Pagel, MD. PARACEST MRI with improved temporal resolution. Magn Reson Med 2009, 61:399–408.
Sheth, VR, Li, Y, Chen, LQ, Howison, CM, Flask, CA, Pagel, MD. Measuring in vivo tumor pHe with CEST‐FISP MRI. Magn Reson Med 2011, 67:760–768.
Aime, S, Delli Castelli, D, Terreno, E. Highly sensitive MRI chemical exchange saturation transfer agents using liposomes. Angew Chem Int Ed Engl 2005, 44:5513–5515.
Aime, S, Delli Castelli, D, Lawson, D, Terreno, E. Gd‐loaded liposomes as T1, susceptibility, and CEST agents, all in one. J Am Chem Soc 2007, 129: 2430–2431.
Terreno, E, Cabella, C, Carrera, C, Delli Castelli, D, Mazzon, R, Rollet, S, Stancanello, J, Visigalli, M, Aime, S. From spherical to osmotically shrunken paramagnetic liposomes: an improved generation of LIPOCEST MRI agents with highly shifted water protons. Angew Chem Int Ed Engl 2007, 46:966–968.
Delli Castelli, D, Terreno, E, Carrera, C, Giovenzana, GB, Mazzon, R, Rollet, S, Visigalli, M, Aime, S. Lanthanide‐loaded paramagnetic liposomes as switchable magnetically oriented nanovesicles. Inorg Chem 2008, 47:2928–2930.
Terreno, E, Barge, A, Beltrami, L, Cravotto, G, Castelli, DD, Fedeli, F, Jebasingh, B, Aime, S. Highly shifted LIPOCEST agents based on the encapsulation of neutral polynuclear paramagnetic shift reagents. Chem Commun (Camb) 2008, 5:600–602.
Liu, G, Moake, M, Har‐el, Y‐E, Long, CM, Chan, KW, Cardona, A, Jamil, M, Walczak, P, Gilad, AA, Sgouros, G, et al. In vivo multicolor molecular MR imaging using diamagnetic chemical exchange saturation transfer liposomes. Magn Reson Med 2012. doi:10.1002/mrm.23100.
Snoussi, K, Bulte, JW, Gueron, M, van Zijl, PC. Sensitive CEST agents based on nucleic acid imino proton exchange: detection of poly(rU) and of a dendrimer‐poly(rU) model for nucleic acid delivery and pharmacology. Magn Reson Med 2003, 49:998–1005.
Choi, J, Kim, K, Kim, T, Liu, G, Bar‐Shir, A, Hyeon, T, McMahon, MT, Bulte, JW, Fisher, JP, Gilad, AA. Multimodal imaging of sustained drug release from 3‐D poly(propylene fumarate) (PPF) scaffolds. J Control Release 2011, 156:239–245.
Langereis, S, Keupp, J, van Velthoven, JL, de Roos, IH, Burdinski, D, Pikkemaat, JA, Grull, H. A temperature‐sensitive liposomal 1H CEST and 19F contrast agent for MR image‐guided drug delivery. J Am Chem Soc 2009, 131:1380–1381.
Ali, MM, Yoo, B, Pagel, MD. Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. Mol Pharm 2009, 6:1409–1416.
Winter, PM, Cai, K, Chen, J, Adair, CR, Kiefer, GE, Athey, PS, Gaffney, PJ, Buff, CE, Robertson, JD, Caruthers, SD, et al. Targeted PARACEST nanoparticle contrast agent for the detection of fibrin. Magn Reson Med 2006, 56:1384–1388.
Liu, G, Li, Y, Sheth, VR, Pagel, MD. Imaging In vivo extracellular pH with a single paramagnetic chemical exchange saturation transfer magnetic resonance imaging contrast agent. Mol Imaging 2011. doi:10.2310/7290.2011.00026.
Li, Y, Sheth, VR, Liu, G, Pagel, MD. A self‐calibrating PARACEST MRI contrast agent that detects esterase enzyme activity. Contrast Media Mol Imaging 2011, 6:219–228.
Liu, G, Li, Y, Pagel, MD. Design and characterization of a new irreversible responsive PARACEST MRI contrast agent that detects nitric oxide. Magn Reson Med 2007, 58:1249–1256.
Yoo, B, Pagel, MD. A PARACEST MRI contrast agent to detect enzyme activity. J Am Chem Soc 2006, 128:14032–14033.
Pikkemaat, JA, Wegh, RT, Lamerichs, R, van de Molengraaf, RA, Langereis, S, Burdinski, D, Raymond, AY, Janssen, HM, de Waal, BF, Willard, NP, et al. Dendritic PARACEST contrast agents for magnetic resonance imaging. Contrast Media Mol Imaging 2007, 2:229–239.
Winter, PM, Cai, K, Caruthers, SD, Wickline, SA, Lanza, GM. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles. Expert Rev Med Devices 2007, 4:137–145.
Winter, PM, Caruthers, SD, Allen, JS, Cai, K, Williams, TA, Lanza, GM, Wickline, SA. Molecular imaging of angiogenic therapy in peripheral vascular disease with ανβ3‐integrin‐targeted nanoparticles. Magn Reson Med 2010, 64:369–376.
Winter, PM, Caruthers, SD, Kassner, A, Harris, TD, Chinen, LK, Allen, JS, Lacy, EK, Zhang, H, Robertson, JD, Wickline, SA, et al. Molecular imaging of angiogenesis in nascent Vx‐2 rabbit tumors using a novel α(ν)β3‐targeted nanoparticle and 1.5 tesla magnetic resonance imaging. Cancer Res 2003, 63:5838–5843.
Winter, PM, Caruthers, SD, Zhang, H, Williams, TA, Wickline, SA, Lanza, GM. Antiangiogenic synergism of integrin‐targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. JACC Cardiovasc Imaging 2008, 1:624–634.
Winter, PM, Morawski, AM, Caruthers, SD, Fuhrhop, RW, Zhang, H, Williams, TA, Allen, JS, Lacy, EK, Robertson, JD, Lanza, GM, et al. Molecular imaging of angiogenesis in early‐stage atherosclerosis with α(ν)β3‐integrin‐targeted nanoparticles. Circulation 2003, 108:2270–2274.
Winter, PM, Neubauer, AM, Caruthers, SD, Harris, TD, Robertson, JD, Williams, TA, Schmieder, AH, Hu, G, Allen, JS, Lacy, EK, et al. Endothelial α(ν)β3 integrin‐targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 2006, 26:2103–2109.
Winter, PM, Schmieder, AH, Caruthers, SD, Keene, JL, Zhang, H, Wickline, SA, Lanza, GM. Minute dosages of α(ν)β3‐targeted fumagillin nanoparticles impair Vx‐2 tumor angiogenesis and development in rabbits. FASEB J 2008, 22:2758–2767.
Flacke, S, Fischer, S, Scott, MJ, Fuhrhop, RJ, Allen, JS, McLean, M, Winter, P, Sicard, GA, Gaffney, PJ, Wickline, SA, et al. Novel MRI contrast agent for molecular imaging of fibrin: implications for detecting vulnerable plaques. Circulation 2001, 104:1280–1285.
Winter, PM, Caruthers, SD, Yu, X, Song, SK, Chen, J, Miller, B, Bulte, JW, Robertson, JD, Gaffney, PJ, Wickline, SA, et al. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med 2003, 50:411–416.
Morawski, AM, Winter, PM, Yu, X, Fuhrhop, RW, Scott, MJ, Hockett, F, Robertson, JD, Gaffney, PJ, Lanza, GM, Wickline, SA. Quantitative “magnetic resonance immunohistochemistry” with ligand‐targeted (19)F nanoparticles. Magn Reson Med 2004, 52:1255–1262.
Neubauer, AM, Myerson, J, Caruthers, SD, Hockett, FD, Winter, PM, Chen, J, Gaffney, PJ, Robertson, JD, Lanza, GM, Wickline, SA. Gadolinium‐modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imaging. Magn Reson Med 2008, 60:1066–1072.
Aime, S, Barge, A, Delli Castelli, D, Fedeli, F, Mortillaro, A, Nielsen, FU, Terreno, E. Paramagnetic lanthanide(III) complexes as pH‐sensitive chemical exchange saturation transfer (CEST) contrast agents for MRI applications. Magn Reson Med 2002, 47:639–648.
Terreno, E, Castelli, DD, Cravotto, G, Milone, L, Aime, S. Ln(III)‐DOTAMGly complexes: a versatile series to assess the determinants of the efficacy of paramagnetic chemical exchange saturation transfer agents for magnetic resonance imaging applications. Invest Radiol 2004, 39:235–243.
Zhang, S, Malloy, CR, Sherry, AD. MRI thermometry based on PARACEST agents. J Am Chem Soc 2005, 127:17572–17573.
Aime, S, Delli Castelli, D, Fedeli, F, Terreno, E. A paramagnetic MRI‐CEST agent responsive to lactate concentration. J Am Chem Soc 2002, 124:9364–9365.
Trokowski, R, Zhang, S, Sherry, AD. Cyclen‐based phenylboronate ligands and their Eu3+ complexes for sensing glucose by MRI. Bioconjug Chem 2004, 15:1431–1440.
Trokowski, R, Ren, J, Kalman, FK, Sherry, AD. Selective sensing of zinc ions with a PARACEST contrast agent. Angew Chem Int Ed Engl 2005, 44:6920–6923.